Predicting Who Benefits From Robotic Walking Training in Neurological Disease
Studies which adults with neurological conditions respond to robotic gait training.
Plain-language title generated from the registry record
Registry title: Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
Key facts
- Where
- Milan, ItalySee the site
Where in Italy
- Don Gnocchi FoundationMilan, ItalyTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione Don Carlo Gnocchi ETS
- Trial code
- NCT05493514
- Record updated
- 9 August 2022
- Original description
The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatmentRead full original descriptionShow less
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System: an Observational Longitudinal Study
The aim of this work is to elaborate a statistical model to predict the effectiveness of robotic treatment in subjects with neurological diseases. The model will be used to understand which subjects are most responsive to this type of treatment
Inclusion: Diagnosis of Multiple Sclerosis, Parkinson Disease, Stroke or acquired brain injury; Minimum number of sessions: 10 sessions with the GEO system; Minimum frequency of sessions: 2 per week; Age ≥ 18 years; Ability to walk for at least 10 meters, also with aid; Indication of robotic treatment in the therapeutic plan; Body size suitable for the robotic device; ability to maintain verticality for 7 minutes; ability to maintain the sitting position without support for 30 seconds.
Exclusion: Presence of seizures that may be triggered by the use of the G-EO system; severe limitations of articular range of motion; medical problems compromising walking (e.g. fractures, pain, severe osteoporosis or severe spasticity); Presence of skin lesions in the areas of contact with the device.